Scientists described the identification and characterization of INCB086550, a novel, oral, small-molecule PD-L1 inhibitor.
[Cancer Discovery]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Human Immunology News Characterization of INCB086550, a Potent and Novel Small-Molecule PD-L1 Inhibitor
